Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Galmed Pharmaceutica (NQ: GLMD )

2.590 USD -0.060 (-2.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 360,907
Open 2.540
Bid (Size) 2.560 (20)
Ask (Size) 2.700 (50)
Prev. Close 2.650
Today's Range 2.510 - 2.700
52wk Range 2.250 - 6.290
Shares Outstanding 21,325,975
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Galmed Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Business Update on Thursday May 13
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator,... 
From PR Newswire
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study
China to Join Galmed's Phase 3 ARMOR Registrational Study for the Treatment of NASH & Fibrosis 
From PR Newswire

Performance

YTD
-18.81%
-18.81%
1 Month
-21.52%
-21.52%
3 Month
-43.82%
-43.82%
6 Month
-15.36%
-15.36%
1 Year
-40.46%
-40.46%

More News

Read More
Ascentage Pharma Appoints Renowned Oncologist Dr. David Sidransky, MD, to its Board as an Independent Non-Executive Director
From PR Newswire
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results
From PR Newswire
Galmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MER
From PR Newswire
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18
From PR Newswire
Week in Review: WHO Close to Approving Global Use for Two China COVID-19 Vaccines
From ChinaBio® Today
Week in Review: WHO Close to Approving Global Use for Two China COVID-19 Vaccines
From ChinaBio® Today
Week In Review: WHO Close To Approving Global Use For Two China COVID-19 Vaccines
Tags Pharma/Biotech Stocks / Equities Market News
From Blogs - TalkMarkets
12 Health Care Stocks Moving In Monday's After-Market Session
Tags BZI/TFM NOVN Market News
From Benzinga
Galmed Adds China Arm to Global Trial of NASH/Fibrosis Treatment
From ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.